Cited by 41RNA Research and SplicingGenetics and Neurodevelopmental DisordersRNA regulation and disease

Mapping PTBP2 binding in human brain identifies SYNGAP1 as a target for therapeutic splice switching

Open access
Dawicki-McKenna, Jennine M., Felix, Alex J., Waxman, Elisa A., Cheng, Congsheng, Amado, Defne A., Ranum, Paul T., Bogush, Alexey, Dungan, Lea V. +6 more·2023·Nature Communications

Published version of a preprint

Abstract

Alternative splicing of neuronal genes is controlled partly by the coordinated action of polypyrimidine tract binding proteins (PTBPs). While PTBP1 is ubiquitously expressed, PTBP2 is predominantly neuronal. Here, we define the PTBP2 footprint in the human transcriptome using brain tissue and human induced pluripotent stem cell-derived neurons (iPSC-neurons). We map PTBP2 binding sites, characterize PTBP2-dependent alternative splicing events, and identify novel PTBP2 targets including SYNGAP1 , a synaptic gene whose loss-of-function leads to a complex neurodevelopmental disorder. We find that PTBP2 binding to SYNGAP1 mRNA promotes alternative splicing and nonsense-mediated decay, and that antisense oligonucleotides (ASOs) that disrupt PTBP binding redirect splicing and increase SYNGAP1 mRNA and protein expression. In SYNGAP1 haploinsufficient iPSC-neurons generated from two patients, we show that PTBP2-targeting ASOs partially restore SYNGAP1 expression. Our data comprehensively map PTBP2-dependent alternative splicing in human neurons and cerebral cortex, guiding development of novel therapeutic tools to benefit neurodevelopmental disorders.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-023-38273-3

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Prior mechanistic studies have shown that PTBP1 normally suppresses productive expression of PTBP2 through alternative splicing coupled to nonsense-mediated decay.

    “Prior mechanistic studies have shown that PTBP1 normally suppresses productive expression of PTBP2 through alternative splicing coupled to nonsense-mediated decay.”

    From Reverse the progression of Alzheimer’s disease through Nano-ERASER-based adult neuroregeneration (2026) · cites this paper as [22]

    The Results section on PTBP2-dependent synaptic genes reports that PTBP1 levels fall while PTBP2 levels rise during neuronal differentiation, but it does not say that PTBP1 suppresses PTBP2 expression. Searches for PTBP1, PTBP2, alternative splicing, and nonsense-mediated decay found NMD mechanisms involving SYNGAP1, not PTBP2. No page numbers are available in our copy. (LLM, conf=0.75)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 48

  1. [1]Raj B Blencowe BJ Alternative splicing in the mammalian nervous system: recent insights into mechanisms and functional roles Neuron 2015 87 14 27 10.1016/j.neuron.2015.05.004 26139367 · DOI · Paper page
  2. [2]Vuong CK Black DL Zheng S The neurogenetics of alternative splicing Nat. Rev. Neurosci. 2016 17 265 281 10.1038/nrn.2016.27 27094079 PMC4861142 · DOI · Paper page
  3. [3]Su CH Dhananjaya D Tarn WY Alternative splicing in neurogenesis and brain development Front Mol. Biosci. 2018 5 12 10.3389/fmolb.2018.00012 29484299 PMC5816070 · DOI
  4. [5]Crooke ST Liang XH Baker BF Crooke RM Antisense technology: a review J. Biol. Chem. 2021 296 100416 100417 10.1016/j.jbc.2021.100416 33600796 PMC8005817 · DOI
  5. [6]Lim KH Antisense oligonucleotide modulation of non-productive alternative splicing upregulates gene expression Nat. Commun. 2020 11:1 2020 11 1 13 PMC7347940 32647108
  6. [8]Hua Y Vickers TA Okunola HL Bennett CF Krainer AR Antisense masking of an hnRNP A1/A2 intronic splicing silencer corrects SMN2 splicing in transgenic mice Am. J. Hum. Genet. 2008 82 834 848 10.1016/j.ajhg.2008.01.014 18371932 PMC2427210 · DOI
  7. [9]Finkel RS Nusinersen versus sham control in infantile-onset spinal muscular atrophy N. Engl. J. Med. 2017 377 1723 1732 10.1056/NEJMoa1702752 29091570 · DOI · Paper page
  8. [10]Weyn-Vanhentenryck SM Precise temporal regulation of alternative splicing during neural development Nat. Commun. 2018 9 1 17 10.1038/s41467-018-04559-0 29875359 PMC5989265 · DOI
  9. [11]Li, Q. et al. The splicing regulator PTBP2 controls a program of embryonic splicing required for neuronal maturation. Elife3, e01201 (2014). PMC3896118 24448406
  10. [12]Licatalosi DD Ptbp2 represses adult-specific splicing to regulate the generation of neuronal precursors in the embryonic brain Genes Dev. 2012 26 1626 1642 10.1101/gad.191338.112 22802532 PMC3404389 · DOI · Paper page
  11. [13]van Nostrand EL Principles of RNA processing from analysis of enhanced CLIP maps for 150 RNA binding proteins Genome Biol. 2020 21 90 10.1186/s13059-020-01982-9 32252787 PMC7137325 · DOI
  12. [14]Zhang M Axonogenesis is coordinated by neuron-specific alternative splicing programming and splicing regulator PTBP2 Neuron 2019 101 690 706.e10 10.1016/j.neuron.2019.01.022 30733148 PMC6474845 · DOI
  13. [15]Hamdan FF Mutations in SYNGAP1 in autosomal nonsyndromic mental retardation N. Engl. J. Med. 2009 360 599 605 10.1056/NEJMoa0805392 19196676 PMC2925262 · DOI · Paper page
  14. [17]Berryer MH Mutations in SYNGAP1 cause intellectual disability, autism, and a specific form of epilepsy by inducing haploinsufficiency Hum. Mutat. 2013 34 385 394 10.1002/humu.22248 23161826 · DOI · Paper page
  15. [18]Linares AJ The splicing regulator PTBP1 controls the activity of the transcription factor Pbx1 during neuronal differentiation Elife 2015 4 e09268 10.7554/eLife.09268 26705333 PMC4755740 · DOI
  16. [19]Markovtsov V Cooperative assembly of an hnRNP complex induced by a tissue-specific homolog of polypyrimidine tract binding protein Mol. Cell Biol. 2000 20 7463 7479 10.1128/MCB.20.20.7463-7479.2000 11003644 PMC86300 · DOI
  17. [20]Koopmans F SynGO: an evidence-based, expert-curated knowledge base for the synapse Neuron 2019 103 217 234.e4 10.1016/j.neuron.2019.05.002 31171447 PMC6764089 · DOI · Paper page
  18. [21]Shen S rMATS: robust and flexible detection of differential alternative splicing from replicate RNA-Seq data Proc. Natl. Acad. Sci. USA 2014 111 E5593 E5601 10.1073/pnas.1419161111 25480548 PMC4280593 · DOI · Paper page
  19. [23]Zhang Z Xing Y CLIP-seq analysis of multi-mapped reads discovers novel functional RNA regulatory sites in the human transcriptome Nucleic Acids Res. 2017 45 9260 9271 10.1093/nar/gkx646 28934506 PMC5766199 · DOI
  20. [24]Yee BA Pratt GA Graveley BR van Nostrand EL Yeo GW RBP-Maps enables robust generation of splicing regulatory maps RNA 2019 25 193 204 10.1261/rna.069237.118 30413564 PMC6348990 · DOI
  21. [25]Gamache TR Araki Y Huganir RL Twenty years of SynGAP research: from synapses to cognition J. Neurosci. 2020 40 1596 1605 10.1523/JNEUROSCI.0420-19.2020 32075947 PMC7046327 · DOI · Paper page
  22. [26]Vuong JK PTBP1 and PTBP2 serve both specific and redundant functions in neuronal pre-mRNA splicing Cell Rep. 2016 17 2766 2775 10.1016/j.celrep.2016.11.034 27926877 PMC5179036 · DOI
  23. [27]Boutz PL A post-transcriptional regulatory switch in polypyrimidine tract-binding proteins reprograms alternative splicing in developing neurons Genes Dev. 2007 21 1636 1652 10.1101/gad.1558107 17606642 PMC1899473 · DOI · Paper page
  24. [28]Makeyev EV Zhang J Carrasco MA Maniatis T The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing Mol. Cell 2007 27 435 448 10.1016/j.molcel.2007.07.015 17679093 PMC3139456 · DOI · Paper page
  25. [29]Denichenko P Specific inhibition of splicing factor activity by decoy RNA oligonucleotides Nat. Commun. 2019 10 1 15 10.1038/s41467-019-09523-0 30962446 PMC6453957 · DOI
  26. [30]Liang XH Nichols JG Hsu CW Vickers TA Crooke ST mRNA levels can be reduced by antisense oligonucleotides via no-go decay pathway Nucleic Acids Res. 2019 47 6900 6916 10.1093/nar/gkz500 31165876 PMC6649848 · DOI
  27. [31]Saulière J Sureau A Expert-Bezançon A Marie J The polypyrimidine tract binding protein (PTB) represses splicing of exon 6B from the β-tropomyosin pre-mRNA by directly interfering with the binding of the U2AF65 subunit Mol. Cell Biol. 2006 26 8755 8769 10.1128/MCB.00893-06 16982681 PMC1636812 · DOI
  28. [32]Yap K Lim ZQ Khandelia P Friedman B Makeyev EV Coordinated regulation of neuronal mRNA steady-state levels through developmentally controlled intron retention Genes Dev. 2012 26 1209 1223 10.1101/gad.188037.112 22661231 PMC3371409 · DOI · Paper page
  29. [35]Paradis C hnRNP I/PTB can antagonize the splicing repressor activity of SRp30c RNA 2007 13 1287 1300 10.1261/rna.403607 17548433 PMC1924885 · DOI
  30. [36]Han A De novo prediction of PTBP1 binding and splicing targets reveals unexpected features of its RNA recognition and function PLoS Comput. Biol. 2014 10 e1003442 10.1371/journal.pcbi.1003442 24499931 PMC3907290 · DOI
  31. [37]Karousis ED Gypas F Zavolan M Mühlemann O Nanopore sequencing reveals endogenous NMD-targeted isoforms in human cells Genome Biol. 2021 22 223 10.1186/s13059-021-02439-3 34389041 PMC8361881 · DOI
  32. [38]Telezhkin V Forced cell cycle exit and modulation of GABAA, CREB, and GSK3β signaling promote functional maturation of induced pluripotent stem cell-derived neurons Am. J. Physiol. Cell Physiol. 2016 310 C520 C541 10.1152/ajpcell.00166.2015 26718628 · DOI
  33. [39]Yan Y Efficient and rapid derivation of primitive neural stem cells and generation of brain subtype neurons from human pluripotent stem cells Stem Cells Transl. Med. 2013 2 862 870 10.5966/sctm.2013-0080 24113065 PMC3808201 · DOI
  34. [40]Maguire JA Generation of human control iPS cell line CHOPWT10 from healthy adult peripheral blood mononuclear cells Stem Cell Res. 2016 16 338 341 10.1016/j.scr.2016.02.017 27345999 · DOI
  35. [41]Ho SM Rapid Ngn2-induction of excitatory neurons from hiPSC-derived neural progenitor cells Methods 2016 101 113 124 10.1016/j.ymeth.2015.11.019 26626326 PMC4860098 · DOI
  36. [42]Yang, W. et al. iPSC reprogramming from human peripheral blood using Sendai Virus mediated gene transfer. StemBook (Stem Book, 2014). 10.3824/STEMBOOK.1.73.1. 23785736 · DOI
  37. [43]Maguire JA Cardenas-Diaz FL Gadue P French DL Highly efficient CRISPR-Cas9-mediated genome editing in human pluripotent stem cells Curr. Protoc. Stem Cell Biol. 2019 48 e64 10.1002/cpsc.64 30358158 PMC6336498 · DOI
  38. [44]Love MI Tximeta: Reference sequence checksums for provenance identification in RNA-seq PLoS Comput. Biol. 2020 16 e1007664 10.1371/journal.pcbi.1007664 32097405 PMC7059966 · DOI
  39. [46]Love MI Huber W Anders S Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 Genome Biol. 2014 15 1 21 10.1186/s13059-014-0550-8 PMC4302049 25516281 · DOI · Paper page
  40. [47]Zhu A Ibrahim JG Love MI Heavy-tailed prior distributions for sequence count data: removing the noise and preserving large differences Bioinformatics 2019 35 2084 2092 10.1093/bioinformatics/bty895 30395178 PMC6581436 · DOI
  41. [48]Wu T clusterProfiler 4.0: a universal enrichment tool for interpreting omics data Innovation 2021 2 100141 34557778 PMC8454663
  42. [49]Veeneman BA Shukla S Dhanasekaran SM Chinnaiyan AM Nesvizhskii AI Two-pass alignment improves novel splice junction quantification Bioinformatics 2016 32 43 49 10.1093/bioinformatics/btv642 26519505 PMC5006238 · DOI
  43. [51]Hahne F Ivanek R Visualizing genomic data using Gviz and bioconductor Methods Mol. Biol. 2016 1418 335 351 10.1007/978-1-4939-3578-9_16 27008022 · DOI
  44. [52]van Nostrand EL Robust transcriptome-wide discovery of RNA-binding protein binding sites with enhanced CLIP (eCLIP) Nat. Methods 2016 13 508 514 10.1038/nmeth.3810 27018577 PMC4887338 · DOI · Paper page
  45. [53]Spengler RM Elucidation of transcriptome-wide microRNA binding sites in human cardiac tissues by Ago2 HITS-CLIP Nucleic Acids Res. 2016 44 7120 7131 27418678 PMC5009757
  46. [54]He C TET2 chemically modifies tRNAs and regulates tRNA fragment levels Nat. Struct. Mol. Biol. 2021 28 62 70 10.1038/s41594-020-00526-w 33230319 PMC7855721 · DOI
  47. [55]Dunham I An integrated encyclopedia of DNA elements in the human genome Nature 2012 489 57 74 10.1038/nature11247 22955616 PMC3439153 · DOI · Paper page
  48. [56]Zabolocki M BrainPhys neuronal medium optimized for imaging and optogenetics in vitro Nat. Commun. 2020 11 1 19 10.1038/s41467-020-19275-x 33144563 PMC7642238 · DOI

Cited by

Sorted by citations

Authors
Dawicki-McKenna, J. M., Felix, A. J., Waxman, E. A., Cheng, C., Amado, D. A., Ranum, P. T., Bogush, A., Dungan, L. V., Maguire, J. A., Gagne, A. L., Heller, E. A., French, D. L., Davidson, B. L., & Prosser, B. L.
Affiliations
Children's Hospital of Philadelphia (US)
Corresponding author
  • Davidson, Beverly L.
  • Prosser, Benjamin L.
Venue
Nature Communications
Published
2023-05-06
Volume
14
Issue
1
Pages
2628-2628
ISSN
2041-1723 (ISSN-L)
OpenAlex
W4372352541
Cited by
41
References
6
Citations by year
2026: 15 · 2025: 11 · 2024: 9 · 2023: 6
FWCI
3.65
Type
journal article
Language
en
Open access
Locations
  • Nature Communications (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NS118280)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
Keywords
PTBP2, alternative splicing, SYNGAP1, polypyrimidine tract-binding protein, nonsense-mediated mRNA decay, antisense oligonucleotides, splice switching, iPSC-derived neurons, haploinsufficiency, neurodevelopmental disorders, human transcriptome, cerebral cortex, synaptic genes
MeSH terms
Brain, Humans, Nerve Tissue Proteins, RNA Splicing, RNA, Messenger, Alternative Splicing, ras GTPase-Activating Proteins, Heterogeneous-Nuclear Ribonucleoproteins, Polypyrimidine Tract-Binding Protein, Induced Pluripotent Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review